Cargando…

Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe – a systematic review of the literature

BACKGROUND: Given the increasing incidence in cutaneous malignant melanoma (CMM) and the recent changes in the treatment landscape, it is important to understand stage-specific overall and recurrence-free survival patterns in Europe. Despite publications such as EUROCARE-5, there is limited informat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Svedman, Fernanda Costa, Pillas, Demetris, Taylor, Aliki, Kaur, Moninder, Linder, Ragnar, Hansson, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887072/ https://www.ncbi.nlm.nih.gov/pubmed/27307765 http://dx.doi.org/10.2147/CLEP.S99021

Ejemplares similares

Cross-sectional study on comorbidities and adverse events in patients with advanced and recurrent ovarian cancer in France
por: Le Saux, Olivia, et al.
Publicado: (2015)

Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma
por: Svedman, Fernanda Costa, et al.
Publicado: (2018)

Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status
por: Das, Ishani, et al.
Publicado: (2019)

Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma
por: Costa Svedman, Fernanda, et al.
Publicado: (2022)

The Influence of Pregnancy on the Recurrence of Cutaneous Malignant Melanoma in Women
por: Albersen, M., et al.
Publicado: (2010)

Immunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant Melanoma
por: Rad Pour, Soudabeh, et al.
Publicado: (2020)

Challenges in staging and surveillance of patients with neurofibromatosis and cutaneous malignant melanoma
por: Chew, P.R., et al.
Publicado: (2019)

Staging of cutaneous melanoma
por: Mohr, P., et al.
Publicado: (2009)

Imaging tests in cutaneous malignant melanoma staging: a retrospective cohort()()
por: Souza, Luiza Boava, et al.
Publicado: (2020)

Cutaneous malignant melanoma in Scotland.
por: MacKie, R. M., et al.
Publicado: (1982)

MALIGNANT MELANOMA – CUTANEOUS METASTASES
por: Padmavathy, L, et al.
Publicado: (2008)

Cutaneous Horn Malignant Melanoma
por: Nishida, Haruto, et al.
Publicado: (2013)

Cutavirus in Cutaneous Malignant Melanoma
por: Mollerup, Sarah, et al.
Publicado: (2017)

Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients
por: Atzpodien, J, et al.
Publicado: (2007)

Cutaneous malignant melanoma in Northern Ireland.
por: Pedlow, P. J., et al.
Publicado: (1997)

Primary cutaneous malignant melanoma of the breast
por: Kim, Seon Kwang, et al.
Publicado: (2012)

Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma.
por: Karjalainen, J. M., et al.
Publicado: (1998)

Problems with registration of cutaneous malignant melanoma in England.
por: Melia, J., et al.
Publicado: (1995)

Cutaneous malignant melanoma “recurred as” or “in coexistence” with meningioma?
por: Rahmah, Nunung Nur, et al.
Publicado: (2010)

Worldwide Increasing Incidences of Cutaneous Malignant Melanoma
por: Godar, Dianne E.
Publicado: (2011)

Diffuse Cutaneous Melanosis Associated with Malignant Melanoma
por: Mangana, Joanna, et al.
Publicado: (2015)

Established and Emerging Biomarkers in Cutaneous Malignant Melanoma
por: Verykiou, Stamatina, et al.
Publicado: (2014)

Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma
por: Das, Ishani, et al.
Publicado: (2020)

Primary Cilium Depletion Typifies Cutaneous Melanoma In Situ and Malignant Melanoma
por: Kim, Jinah, et al.
Publicado: (2011)

Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma
por: Falkenius, Johan, et al.
Publicado: (2017)

AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanoma
por: Das, Ishani, et al.
Publicado: (2020)

Genetic determinants of cutaneous malignant melanoma in Sinclair swine.
por: Blangero, J., et al.
Publicado: (1996)

Metastatic breast disease from cutaneous malignant melanoma()
por: Moschetta, Marco, et al.
Publicado: (2013)

Cutaneous malignant melanoma in two rabbits (Oryctolagus cuniculus)
por: UEDA, Kengo, et al.
Publicado: (2018)

Clinicopathologic Features of Cutaneous Malignant Melanoma and Their Impact on Prognosis
por: Atique, Usman, et al.
Publicado: (2020)

Patterns of Recurrence of Cutaneous Melanoma: A Literature Review
por: Peirano, Dominga, et al.
Publicado: (2023)

Biologically efficient solar radiation: Vitamin D production and induction of cutaneous malignant melanoma
por: Grigalavicius, Mantas, et al.
Publicado: (2013)

Initial Stage of Cutaneous Primary Melanoma Plays a Key Role in the Pattern and Timing of Disease Recurrence
por: ERTEKIN, Sümeyre Seda, et al.
Publicado: (2021)

Sunburn, suntan and the risk of cutaneous malignant melanoma--The Western Canada Melanoma Study.
por: Elwood, J. M., et al.
Publicado: (1985)

Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma
por: Sandru, Angela, et al.
Publicado: (2014)

RECURRENT OVARIAN MALIGNANCY PRESENTING AS CUTANEOUS METASTASIS
por: Karpate, Shilpaja J, et al.
Publicado: (2009)

Cutaneous malignant melanoma in West Yorkshire: II. A prospective study of recurrence and prediction of lymph nodal metastasis.
por: Eastwood, J., et al.
Publicado: (1984)

Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells
por: Azimi, Alireza, et al.
Publicado: (2017)

Clinical Characteristics of Cutaneous Melanoma and Second Primary Malignancies in a Dutch Hospital-Based Cohort of Cutaneous Melanoma Patients
por: van der Velden, Haike M. J., et al.
Publicado: (2009)

Dermoscopic features in different dermatopathological stages of cutaneous melanomas
por: Podolec, Katarzyna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b62s2kdhg7brnqrns7kqv88emg